
        <!DOCTYPE html>
    <html lang="ja">
    <style>
    body
    {
        color: black;
        background-color: white;
    }
    div{
        font-size: 14px;
    }
    span
    {
        font-size: 18px;
    }
    #grad1{
        background: linear-gradient(transparent 60%,#99e4f1 30%);
        font-size: 18px;
        font-weight: bold;
    }
    #grad2{
        background: linear-gradient(transparent 60%,#fda1a1 30%);
        font-size: 18px;
        font-weight: bold;
    }

    </style>

    <head>
        <meta charset="UTF-8">
        <title>101-196</title>
    </head>

    <body>
        <h1>
        <a href="./101_195.html" rel="external" title="prev">≪</a>
        101-196
        <a href="./101_197.html" rel="external" title="next">≫</a>
        </h1>
        <div class='problem'>
            <p>
                <span id="grad1">　問題文　</span>
            </p>
            <p>
                <p>65歳女性。体重50kg。術後肺炎を発症し、メチシリン耐性黄色ブドウ球菌(MRSA)と緑膿菌による複合感染症と診断され、アルベカシン硫酸塩とピペラシリンナトリウムの各注射液が静脈内投与された。なお、この女性の腎機能は正常である。</p>
<h4>問196</h4>
<p>アルベカシン硫酸塩の最も適切な投与法はどれか。1つ選べ。</p>
<ol><li>1回50mg、60分かけての点滴投与を1日1回、数日間にわたって実施した。</li><li>1回50mg、4時間かけての点滴投与を1日1回、数日間にわたって実施した。</li><li>1回200mg、60分かけての点滴投与を1日1回、数日間にわたって実施した。</li><li>1回200mgワン・ショットでの静脈内投与を1日3回、数日間にわたって実施した。</li><li>1回200mg、24時間かけての持続点滴投与を数日間にわたって実施した。</li></ol>
<h4>問197</h4>
<p>アミノグリコシド系抗生物質とβ-ラクタム系抗生物質の両水溶液を混合して残存率を測定したところ、下のようなグラフが得られた。ただし、横軸は時間(h)、縦軸は抗生物質の残存率(%)を片対数プロットしたものである。このグラフでBは(　①　)である。また、このグラフからBは(　②　)に従って分解していると考えられる。</p>
<p>①、②の組合せとして正しいのはどれか。1つ選べ。</p>
<p><img alt="" class="alignnone size-full wp-image-3649" height="297.5" loading="lazy" sizes="(max-width: 383px) 100vw, 383px" src="data:;base64,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" width="268.09999999999997"/></p>
<ul><li>　　　　　①　　　　　　　　　　②</li></ul>
<ol><li>アミノグリコシド系抗生物質　　 0次反応</li><li>β-ラクタム系抗生物質　　　　　0次反応</li><li>アミノグリコシド系抗生物質　　 1次反応</li><li>β-ラクタム系抗生物質　　　　　1次反応</li><li>アミノグリコシド系抗生物質　　 2次反応</li><li>β-ラクタム系抗生物質　　　　　2次反応</li></ol>
<div class="information-box common-icon-box">この問題は、図が不適切という理由から「解なし」となった問題です。</div>    
            </p>
        </div>
        <hr>

        <input type="button" value="check ans" onclick="toggle_switch()"/>
        
        <div id='toggle'>
        <div class='answer'>
            <p>
                <span id="grad2">　解答　　</span>
            </p>
            <p>
            問196：3問197：解なし
            </p>
        </div>
        <div class='description'>
            <p>
                <span id="grad2">　解説　　</span>
            </p>
            <h4>問196</h4>
<p>アルベカシンは、アミノグリコシド系抗生物質の一種です。<strong>アミノグリコシド系抗生物質は濃度依存性</strong>の抗菌薬です。時間に依存するわけではないので一回の投与で濃度をぐっとあげるのが望ましい使用法です。そのため、１日「１回」となっている選択肢 1 ～ 3 が正解の候補です。</p>
<p>そして、１回あたりの量と注射にどれくらい時間をかけるかは知っていないとどうしようもないかなと思います。MRSA に対する代表的な薬剤なので詳しく覚えておいてほしい　という意図が感じられます。正解は 3 です。</p>
<p>類題　</p>
<h4>問197</h4>
<p>解なしのため、解説なし。</p>
            </p>
        </div>
        </div>
    </body>
    <script>
    document.getElementById("toggle").style.display="none";
    function toggle_switch(){
        var x = document.getElementById("toggle");
        if (x.style.display=="block"){
            x.style.display="none";
        }
        else{
            x.style.display="block";
        }
    }
    </script>
    